Cellular growth factors in relation to mortality from cardiovascular disease in middle-aged Japanese: the JACC study

Hiroyasu Iso1, Koutatsu Maruyama, Satoyo Ikehara

  • 1Public Health, Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, Japan. iso@pbhel.med.osaka-u.ac.jp

Atherosclerosis
|August 4, 2012
PubMed

Insights

Insulin-like growth factor I (IGF-I) was linked to lower intraparenchymal hemorrhage risk, while transforming growth factor beta 1 (TGF-β1) was associated with reduced ischemic stroke mortality. These findings suggest cellular growth factors may influence stroke development.

Area of Science:

  • Cardiovascular Epidemiology
  • Biomarkers in Disease
  • Cellular Biology and Disease Mechanisms

Background:

  • Limited population-based data exists on cellular growth factors and cardiovascular disease.
  • Cellular growth factors play roles in cell proliferation and tissue repair, potentially impacting cardiovascular health.

Purpose of the Study:

  • To investigate the association between specific cellular growth factors and mortality from stroke and coronary heart disease.
  • To explore the potential role of cellular proliferation in cardiovascular disease outcomes.

Main Methods:

  • A nested case-control study within the JACC prospective cohort (39,242 participants aged 40-79).
  • Measurement of serum insulin-like growth factors I, II (IGF-I, IGF-II), binding protein-3 (IGFBP-3), and transforming growth factor beta 1 (TGF-β1).
  • Matching of cases and controls for sex, age, residence, and serum storage year.

Main Results:

  • A 9-year follow-up identified 233 stroke deaths and 97 coronary heart disease deaths.
  • Higher IGF-I levels showed an inverse association with intraparenchymal hemorrhage mortality (OR 0.31; 95% CI 0.14-0.71).
  • Higher TGF-β1 levels were inversely associated with ischemic stroke mortality (OR 0.58; 95% CI 0.34-0.98).
  • IGF-II and IGFBP-3 were not significantly associated with any studied mortality outcomes.

Conclusions:

  • IGF-I is inversely associated with intraparenchymal hemorrhage mortality.
  • TGF-β1 is inversely associated with ischemic stroke mortality.
  • These findings suggest a role for cellular proliferation in stroke pathogenesis or prognosis.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...